TY - JOUR AU - Mahindra, A. AU - Laubach, J. AU - Raje, N. AU - Munshi, N. AU - Richardson, P. G. AU - Anderson, K. PY - 2012 DA - 2012// TI - Latest advances and current challenges in the treatment of multiple myeloma JO - Nat Rev Clin Oncol VL - 9 UR - https://doi.org/10.1038/nrclinonc.2012.15 DO - 10.1038/nrclinonc.2012.15 ID - Mahindra2012 ER - TY - JOUR AU - Joao, C. AU - Costa, C. AU - Coelho, I. AU - Vergueiro, M. J. AU - Ferreira, M. AU - Silva, M. G. PY - 2014 DA - 2014// TI - Long-term survival in multiple myeloma JO - Clin Case Rep VL - 2 UR - https://doi.org/10.1002/ccr3.76 DO - 10.1002/ccr3.76 ID - Joao2014 ER - TY - JOUR AU - Bianchi, G. AU - Munshi, N. C. PY - 2015 DA - 2015// TI - Pathogenesis beyond the cancer clone(s) in multiple myeloma JO - Blood VL - 125 UR - https://doi.org/10.1182/blood-2014-11-568881 DO - 10.1182/blood-2014-11-568881 ID - Bianchi2015 ER - TY - JOUR AU - Sharma, A. AU - Heuck, C. J. AU - Fazzari, M. J. AU - Mehta, J. AU - Singhal, S. AU - Greally, J. M. PY - 2010 DA - 2010// TI - DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer JO - Wiley Interdiscip Rev Syst Biol Med VL - 2 UR - https://doi.org/10.1002/wsbm.89 DO - 10.1002/wsbm.89 ID - Sharma2010 ER - TY - JOUR AU - Chapman, M. A. AU - Lawrence, M. S. AU - Keats, J. J. AU - Cibulskis, K. AU - Sougnez, C. AU - Schinzel, A. C. PY - 2011 DA - 2011// TI - Initial genome sequencing and analysis of multiple myeloma JO - Nature VL - 471 UR - https://doi.org/10.1038/nature09837 DO - 10.1038/nature09837 ID - Chapman2011 ER - TY - JOUR AU - Dimopoulos, K. AU - Gimsing, P. AU - Gronbaek, K. PY - 2013 DA - 2013// TI - Aberrant microRNA expression in multiple myeloma JO - Eur J Haematol VL - 91 UR - https://doi.org/10.1111/ejh.12124 DO - 10.1111/ejh.12124 ID - Dimopoulos2013 ER - TY - STD TI - Yap TA, Johnson PWM, Winter J, Leonard J, Giulino-Roth L, Horner T, Radswillas K, Carver J, Dhar A. A phase I, open-label study of GSK2816126, an enhancer of zeste homolog 2 (EZH2) inhibitor, in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), transformed follicular lymphoma (tFL), other non-Hodgkin’s lymphomas (NHL), multiple myeloma (MM) and solid tumor. J Clin Onco. 2016;34(suppl 15):TPS2595-TPS2595. ID - ref7 ER - TY - JOUR AU - Laurie Herviou, A. K. AU - Boireau, S. AU - Robert, N. AU - Requirand, G. AU - Vincent, L. AU - Seckinger, A. AU - Goldschmidt, H. AU - Hose, D. AU - Cavalli, G. AU - Moreaux, J. PY - 2016 DA - 2016// TI - Targeting EZH2 in multiple myeloma could be promising for a subgroup of MM patients in combination with IMiDs JO - Blood VL - 128 ID - Laurie Herviou2016 ER - TY - JOUR AU - Richardson, P. AU - Mitsiades, C. AU - Colson, K. AU - Reilly, E. AU - McBride, L. AU - Chiao, J. PY - 2008 DA - 2008// TI - Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma JO - Leuk Lymphoma VL - 49 UR - https://doi.org/10.1080/10428190701817258 DO - 10.1080/10428190701817258 ID - Richardson2008 ER - TY - JOUR AU - Tompkins, J. D. AU - Hall, C. AU - Chen, V. C. AU - Li, A. X. AU - Wu, X. AU - Hsu, D. PY - 2012 DA - 2012// TI - Epigenetic stability, adaptability, and reversibility in human embryonic stem cells JO - Proc Natl Acad Sci U S A VL - 109 UR - https://doi.org/10.1073/pnas.1209620109 DO - 10.1073/pnas.1209620109 ID - Tompkins2012 ER - TY - JOUR AU - Wong, K. Y. AU - Huang, X. AU - Chim, C. S. PY - 2012 DA - 2012// TI - DNA methylation of microRNA genes in multiple myeloma JO - Carcinogenesis VL - 33 UR - https://doi.org/10.1093/carcin/bgs212 DO - 10.1093/carcin/bgs212 ID - Wong2012 ER - TY - JOUR AU - Ahmad, A. AU - Ginnebaugh, K. R. AU - Yin, S. AU - Bollig-Fischer, A. AU - Reddy, K. B. AU - Sarkar, F. H. PY - 2015 DA - 2015// TI - Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4 JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1561-x DO - 10.1186/s12885-015-1561-x ID - Ahmad2015 ER - TY - JOUR AU - Zhang, Q. AU - Padi, S. K. AU - Tindall, D. J. AU - Guo, B. PY - 2014 DA - 2014// TI - Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31 JO - Cell Death Dis VL - 5 UR - https://doi.org/10.1038/cddis.2014.454 DO - 10.1038/cddis.2014.454 ID - Zhang2014 ER - TY - JOUR AU - El-Awady, R. A. AU - Hersi, F. AU - Al-Tunaiji, H. AU - Saleh, E. M. AU - Abdel-Wahab, A. H. AU - Al Homssi, A. PY - 2015 DA - 2015// TI - Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy JO - Cancer Biol Ther VL - 16 UR - https://doi.org/10.1080/15384047.2015.1046023 DO - 10.1080/15384047.2015.1046023 ID - El-Awady2015 ER - TY - JOUR AU - Abdi, J. AU - Jian, H. AU - Chang, H. PY - 2016 DA - 2016// TI - Role of micro-RNAs in drug resistance of multiple myeloma JO - Oncotarget VL - 7 ID - Abdi2016 ER - TY - JOUR AU - Nikesitch, N. AU - Ling, S. C. PY - 2016 DA - 2016// TI - Molecular mechanisms in multiple myeloma drug resistance JO - J Clin Pathol VL - 69 UR - https://doi.org/10.1136/jclinpath-2015-203414 DO - 10.1136/jclinpath-2015-203414 ID - Nikesitch2016 ER - TY - JOUR AU - Heuck, C. H. AU - Mehta, J. AU - Tariman, J. AU - Pulliam, N. AU - Yu, Y. AU - Bhagat, T. AU - Nischal, S. AU - Meagher, R. AU - Hu, C. Y. AU - Verma, A. AU - Singhal, S. B. PY - 2010 DA - 2010// TI - Epigenomic profiling of multiple myeloma shows widespread stage specific alterations in DNA methylation that occur early during myelomagenesis JO - Blood VL - 116 ID - Heuck2010 ER - TY - JOUR AU - Walker, B. A. AU - Wardell, C. P. AU - Chiecchio, L. AU - Smith, E. M. AU - Boyd, K. D. AU - Neri, A. PY - 2011 DA - 2011// TI - Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma JO - Blood VL - 117 UR - https://doi.org/10.1182/blood-2010-04-279539 DO - 10.1182/blood-2010-04-279539 ID - Walker2011 ER - TY - JOUR AU - Tsvetkov, P. AU - Sokol, E. AU - Jin, D. AU - Brune, Z. AU - Thiru, P. AU - Ghandi, M. PY - 2017 DA - 2017// TI - Suppression of 19S proteasome subunits marks emergence of an altered cell state in diverse cancers JO - Proc Natl Acad Sci U S A VL - 114 UR - https://doi.org/10.1073/pnas.1619067114 DO - 10.1073/pnas.1619067114 ID - Tsvetkov2017 ER - TY - JOUR AU - Das, D. S. AU - Ray, A. AU - Das, A. AU - Song, Y. AU - Tian, Z. AU - Oronsky, B. PY - 2016 DA - 2016// TI - A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells JO - Leukemia VL - 30 UR - https://doi.org/10.1038/leu.2016.96 DO - 10.1038/leu.2016.96 ID - Das2016 ER - TY - JOUR AU - Nojima, M. AU - Maruyama, R. AU - Yasui, H. AU - Suzuki, H. AU - Maruyama, Y. AU - Tarasawa, I. PY - 2009 DA - 2009// TI - Genomic screening for genes silenced by DNA methylation revealed an association between RASD1 inactivation and dexamethasone resistance in multiple myeloma JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-3336 DO - 10.1158/1078-0432.CCR-08-3336 ID - Nojima2009 ER - TY - JOUR AU - Mithraprabhu, S. AU - Kalff, A. AU - Chow, A. AU - Khong, T. AU - Spencer, A. PY - 2014 DA - 2014// TI - Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma JO - Epigenetics VL - 9 UR - https://doi.org/10.4161/15592294.2014.983367 DO - 10.4161/15592294.2014.983367 ID - Mithraprabhu2014 ER - TY - JOUR AU - Afifi, S. AU - Michael, A. AU - Azimi, M. AU - Rodriguez, M. AU - Lendvai, N. AU - Landgren, O. PY - 2015 DA - 2015// TI - Role of histone deacetylase inhibitors in relapsed refractory multiple myeloma: a focus on vorinostat and panobinostat JO - Pharmacotherapy VL - 35 UR - https://doi.org/10.1002/phar.1671 DO - 10.1002/phar.1671 ID - Afifi2015 ER - TY - JOUR AU - Hideshima, T. AU - Richardson, P. G. AU - Anderson, K. C. PY - 2011 DA - 2011// TI - Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myeloma JO - Mol Cancer Ther VL - 10 UR - https://doi.org/10.1158/1535-7163.MCT-11-0433 DO - 10.1158/1535-7163.MCT-11-0433 ID - Hideshima2011 ER - TY - JOUR AU - Kikuchi, J. AU - Koyama, D. AU - Wada, T. AU - Izumi, T. AU - Hofgaard, P. O. AU - Bogen, B. PY - 2015 DA - 2015// TI - Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma JO - J Clin Invest VL - 125 UR - https://doi.org/10.1172/JCI80325 DO - 10.1172/JCI80325 ID - Kikuchi2015 ER - TY - JOUR AU - Gollner, S. AU - Oellerich, T. AU - Agrawal-Singh, S. AU - Schenk, T. AU - Klein, H. U. AU - Rohde, C. PY - 2017 DA - 2017// TI - Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia JO - Nat Med VL - 23 UR - https://doi.org/10.1038/nm.4247 DO - 10.1038/nm.4247 ID - Gollner2017 ER - TY - JOUR AU - Kalushkova, A. AU - Fryknas, M. AU - Lemaire, M. AU - Fristedt, C. AU - Agarwal, P. AU - Eriksson, M. PY - 2010 DA - 2010// TI - Polycomb target genes are silenced in multiple myeloma JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0011483 DO - 10.1371/journal.pone.0011483 ID - Kalushkova2010 ER - TY - JOUR AU - Agarwal, P. AU - Alzrigat, M. AU - Parraga, A. A. AU - Enroth, S. AU - Singh, U. AU - Ungerstedt, J. PY - 2016 DA - 2016// TI - Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target JO - Oncotarget VL - 7 ID - Agarwal2016 ER - TY - JOUR AU - Alzrigat, M. AU - Parraga, A. A. AU - Agarwal, P. AU - Zureigat, H. AU - Osterborg, A. AU - Nahi, H. PY - 2017 DA - 2017// TI - EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions JO - Oncotarget VL - 8 ID - Alzrigat2017 ER - TY - JOUR AU - Hernando, H. AU - Gelato, K. A. AU - Lesche, R. AU - Beckmann, G. AU - Koehr, S. AU - Otto, S. PY - 2016 DA - 2016// TI - EZH2 inhibition blocks multiple myeloma cell growth through upregulation of epithelial tumor suppressor genes JO - Mol Cancer Ther VL - 15 UR - https://doi.org/10.1158/1535-7163.MCT-15-0486 DO - 10.1158/1535-7163.MCT-15-0486 ID - Hernando2016 ER - TY - JOUR AU - Zeng, D. AU - Liu, M. AU - Pan, J. PY - 2017 DA - 2017// TI - Blocking EZH2 methylation transferase activity by GSK126 decreases stem cell-like myeloma cells JO - Oncotarget VL - 8 ID - Zeng2017 ER - TY - JOUR AU - Shah, M. Y. AU - Martinez-Garcia, E. AU - Phillip, J. M. AU - Chambliss, A. B. AU - Popovic, R. AU - Ezponda, T. PY - 2016 DA - 2016// TI - MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents JO - Oncogene VL - 35 UR - https://doi.org/10.1038/onc.2016.116 DO - 10.1038/onc.2016.116 ID - Shah2016 ER - TY - JOUR AU - Herviou, L. AU - Cavalli, G. AU - Cartron, G. AU - Klein, B. AU - Moreaux, J. PY - 2016 DA - 2016// TI - EZH2 in normal hematopoiesis and hematological malignancies JO - Oncotarget VL - 7 ID - Herviou2016 ER - TY - JOUR AU - Rukov, J. L. AU - Wilentzik, R. AU - Jaffe, I. AU - Vinther, J. AU - Shomron, N. PY - 2014 DA - 2014// TI - Pharmaco-miR: linking microRNAs and drug effects JO - Brief Bioinform VL - 15 UR - https://doi.org/10.1093/bib/bbs082 DO - 10.1093/bib/bbs082 ID - Rukov2014 ER - TY - JOUR AU - Martino, M. T. AU - Gulla, A. AU - Cantafio, M. E. AU - Lionetti, M. AU - Leone, E. AU - Amodio, N. PY - 2013 DA - 2013// TI - In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma JO - Oncotarget VL - 4 UR - https://doi.org/10.18632/oncotarget.820 DO - 10.18632/oncotarget.820 ID - Martino2013 ER - TY - JOUR AU - Gulla, A. AU - Martino, M. T. AU - Gallo Cantafio, M. E. AU - Morelli, E. AU - Amodio, N. AU - Botta, C. PY - 2016 DA - 2016// TI - A 13 mer LNA-i-miR-221 inhibitor restores drug sensitivity in melphalan-refractory multiple myeloma cells JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-0489 DO - 10.1158/1078-0432.CCR-15-0489 ID - Gulla2016 ER - TY - JOUR AU - Zhao, J. J. AU - Chu, Z. B. AU - Hu, Y. AU - Lin, J. AU - Wang, Z. AU - Jiang, M. PY - 2015 DA - 2015// TI - Targeting the miR-221-222/PUMA/BAK/BAX pathway abrogates dexamethasone resistance in multiple myeloma JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-15-0457 DO - 10.1158/0008-5472.CAN-15-0457 ID - Zhao2015 ER - TY - JOUR AU - Leone, E. AU - Morelli, E. AU - Martino, M. T. AU - Amodio, N. AU - Foresta, U. AU - Gulla, A. PY - 2013 DA - 2013// TI - Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-3325 DO - 10.1158/1078-0432.CCR-12-3325 ID - Leone2013 ER - TY - JOUR AU - Sarkar, S. AU - Dubaybo, H. AU - Ali, S. AU - Goncalves, P. AU - Kollepara, S. L. AU - Sethi, S. PY - 2013 DA - 2013// TI - Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA JO - Am J Cancer Res VL - 3 ID - Sarkar2013 ER - TY - JOUR AU - Bai, H. AU - Wei, J. AU - Deng, C. AU - Yang, X. AU - Wang, C. AU - Xu, R. PY - 2013 DA - 2013// TI - MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen JO - Int J Hematol VL - 97 UR - https://doi.org/10.1007/s12185-012-1256-x DO - 10.1007/s12185-012-1256-x ID - Bai2013 ER - TY - JOUR AU - Gong, C. AU - Yao, Y. AU - Wang, Y. AU - Liu, B. AU - Wu, W. AU - Chen, J. PY - 2011 DA - 2011// TI - Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer JO - J Biol Chem VL - 286 UR - https://doi.org/10.1074/jbc.M110.216887 DO - 10.1074/jbc.M110.216887 ID - Gong2011 ER - TY - JOUR AU - Wei, X. AU - Wang, W. AU - Wang, L. AU - Zhang, Y. AU - Zhang, X. AU - Chen, M. PY - 2016 DA - 2016// TI - MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulating PTEN and PDCD4 JO - Cancer Med VL - 5 UR - https://doi.org/10.1002/cam4.626 DO - 10.1002/cam4.626 ID - Wei2016 ER - TY - JOUR AU - Hu, J. AU - Valckenborgh, E. AU - Xu, D. AU - Menu, E. AU - Raeve, H. AU - Bruyne, E. PY - 2013 DA - 2013// TI - Synergistic induction of apoptosis in multiple myeloma cells by bortezomib and hypoxia-activated prodrug TH-302, in vivo and in vitro JO - Mol Cancer Ther VL - 12 UR - https://doi.org/10.1158/1535-7163.MCT-13-0123 DO - 10.1158/1535-7163.MCT-13-0123 ID - Hu2013 ER - TY - JOUR AU - Fujita, T. AU - Doihara, H. AU - Washio, K. AU - Kawasaki, K. AU - Takabatake, D. AU - Takahashi, H. PY - 2006 DA - 2006// TI - Proteasome inhibitor bortezomib increases PTEN expression and enhances trastuzumab-induced growth inhibition in trastuzumab-resistant cells JO - Anticancer Drugs VL - 17 UR - https://doi.org/10.1097/01.cad.0000198910.90819.06 DO - 10.1097/01.cad.0000198910.90819.06 ID - Fujita2006 ER - TY - JOUR AU - Du, J. AU - Liu, S. AU - He, J. AU - Liu, X. AU - Qu, Y. AU - Yan, W. PY - 2015 DA - 2015// TI - MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.3802 DO - 10.18632/oncotarget.3802 ID - Du2015 ER - TY - JOUR AU - Ballabio, E. AU - Armesto, M. AU - Breeze, C. E. AU - Manterola, L. AU - Arestin, M. AU - Tramonti, D. PY - 2012 DA - 2012// TI - Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)? JO - Blood Cancer J VL - 2 UR - https://doi.org/10.1038/bcj.2012.31 DO - 10.1038/bcj.2012.31 ID - Ballabio2012 ER - TY - JOUR AU - Feng, D. D. AU - Zhang, H. AU - Zhang, P. AU - Zheng, Y. S. AU - Zhang, X. J. AU - Han, B. W. PY - 2011 DA - 2011// TI - Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia JO - J Cell Mol Med VL - 15 UR - https://doi.org/10.1111/j.1582-4934.2010.01213.x DO - 10.1111/j.1582-4934.2010.01213.x ID - Feng2011 ER - TY - JOUR AU - Jagannathan, S. AU - Vad, N. AU - Vallabhapurapu, S. AU - Anderson, K. C. AU - Driscoll, J. J. PY - 2015 DA - 2015// TI - MiR-29b replacement inhibits proteasomes and disrupts aggresome + autophagosome formation to enhance the antimyeloma benefit of bortezomib JO - Leukemia VL - 29 UR - https://doi.org/10.1038/leu.2014.279 DO - 10.1038/leu.2014.279 ID - Jagannathan2015 ER - TY - JOUR AU - Zhang, W. AU - Wang, Y. E. AU - Zhang, Y. AU - Leleu, X. AU - Reagan, M. AU - Mishima, Y. PY - 2014 DA - 2014// TI - Global epigenetic regulation of microRNAs in multiple myeloma JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0110973 DO - 10.1371/journal.pone.0110973 ID - Zhang2014 ER - TY - JOUR AU - Wong, K. Y. AU - So, C. C. AU - Loong, F. AU - Chung, L. P. AU - Lam, W. W. AU - Liang, R. PY - 2011 DA - 2011// TI - Epigenetic inactivation of the miR-124-1 in haematological malignancies JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0019027 DO - 10.1371/journal.pone.0019027 ID - Wong2011 ER - TY - JOUR AU - Yang, Y. AU - Li, F. AU - Saha, M. N. AU - Abdi, J. AU - Qiu, L. AU - Chang, H. PY - 2015 DA - 2015// TI - miR-137 and miR-197 induce apoptosis and suppress tumorigenicity by targeting MCL-1 in multiple myeloma JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-1437 DO - 10.1158/1078-0432.CCR-14-1437 ID - Yang2015 ER - TY - JOUR AU - Qin, Y. AU - Zhang, S. AU - Deng, S. AU - An, G. AU - Qin, X. AU - Li, F. PY - 2017 DA - 2017// TI - Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma JO - Leukemia VL - 31 UR - https://doi.org/10.1038/leu.2016.325 DO - 10.1038/leu.2016.325 ID - Qin2017 ER - TY - JOUR AU - Zhang, B. AU - Ma, L. AU - Wei, J. AU - Hu, J. AU - Zhao, Z. AU - Wang, Y. PY - 2016 DA - 2016// TI - miR-137 suppresses the phosphorylation of AKT and improves the dexamethasone sensitivity in multiple myeloma cells via targeting MITF JO - Curr Cancer Drug Targets VL - 16 UR - https://doi.org/10.2174/1568009616666160203114140 DO - 10.2174/1568009616666160203114140 ID - Zhang2016 ER - TY - STD TI - Viziteu E, Klein B, Basbous J, Lin YL, Hirtz C, Gourzones C, et al. RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma. Leukemia. 2017. ID - ref54 ER - TY - JOUR AU - Kim, Y. AU - Kim, H. AU - Park, D. AU - Jeoung, D. PY - 2015 DA - 2015// TI - miR-335 targets SIAH2 and confers sensitivity to anti-cancer drugs by increasing the expression of HDAC3 JO - Mol Cells VL - 38 UR - https://doi.org/10.14348/molcells.2015.0051 DO - 10.14348/molcells.2015.0051 ID - Kim2015 ER - TY - JOUR AU - Swierczynski, S. AU - Klieser, E. AU - Illig, R. AU - Alinger-Scharinger, B. AU - Kiesslich, T. AU - Neureiter, D. PY - 2015 DA - 2015// TI - Histone deacetylation meets miRNA: epigenetics and post-transcriptional regulation in cancer and chronic diseases JO - Expert Opin Biol Ther VL - 15 UR - https://doi.org/10.1517/14712598.2015.1025047 DO - 10.1517/14712598.2015.1025047 ID - Swierczynski2015 ER - TY - JOUR AU - Min, D. J. AU - Ezponda, T. AU - Kim, M. K. AU - Will, C. M. AU - Martinez-Garcia, E. AU - Popovic, R. PY - 2013 DA - 2013// TI - MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC JO - Leukemia VL - 27 UR - https://doi.org/10.1038/leu.2012.269 DO - 10.1038/leu.2012.269 ID - Min2013 ER - TY - JOUR AU - Shah, M. A. AU - Schwartz, G. K. PY - 2001 DA - 2001// TI - Cell cycle-mediated drug resistance: an emerging concept in cancer therapy JO - Clin Cancer Res VL - 7 ID - Shah2001 ER - TY - JOUR AU - Kim, K. H. AU - Roberts, C. W. PY - 2016 DA - 2016// TI - Targeting EZH2 in cancer JO - Nat Med VL - 22 UR - https://doi.org/10.1038/nm.4036 DO - 10.1038/nm.4036 ID - Kim2016 ER - TY - JOUR AU - Simon, J. A. AU - Lange, C. A. PY - 2008 DA - 2008// TI - Roles of the EZH2 histone methyltransferase in cancer epigenetics JO - Mutat Res VL - 647 UR - https://doi.org/10.1016/j.mrfmmm.2008.07.010 DO - 10.1016/j.mrfmmm.2008.07.010 ID - Simon2008 ER - TY - JOUR AU - Zhao, X. AU - Lwin, T. AU - Zhang, X. AU - Huang, A. AU - Wang, J. AU - Marquez, V. E. PY - 2013 DA - 2013// TI - Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity JO - Leukemia VL - 27 UR - https://doi.org/10.1038/leu.2013.94 DO - 10.1038/leu.2013.94 ID - Zhao2013 ER - TY - JOUR AU - Iorio, M. V. AU - Piovan, C. AU - Croce, C. M. PY - 2010 DA - 2010// TI - Interplay between microRNAs and the epigenetic machinery: an intricate network JO - Biochim Biophys Acta VL - 1799 UR - https://doi.org/10.1016/j.bbagrm.2010.05.005 DO - 10.1016/j.bbagrm.2010.05.005 ID - Iorio2010 ER - TY - JOUR AU - Amodio, N. AU - Stamato, M. A. AU - Gulla, A. M. AU - Morelli, E. AU - Romeo, E. AU - Raimondi, L. PY - 2016 DA - 2016// TI - Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma JO - Mol Cancer Ther VL - 15 UR - https://doi.org/10.1158/1535-7163.MCT-15-0985-T DO - 10.1158/1535-7163.MCT-15-0985-T ID - Amodio2016 ER - TY - JOUR AU - Amodio, N. AU - Rossi, M. AU - Raimondi, L. AU - Pitari, M. R. AU - Botta, C. AU - Tagliaferri, P. PY - 2015 DA - 2015// TI - miR-29 s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.3805 DO - 10.18632/oncotarget.3805 ID - Amodio2015 ER - TY - JOUR AU - Issa, M. E. AU - Takhsha, F. S. AU - Chirumamilla, C. S. AU - Perez-Novo, C. AU - Vanden Berghe, W. AU - Cuendet, M. PY - 2017 DA - 2017// TI - Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma JO - Clin Epigenetics VL - 9 UR - https://doi.org/10.1186/s13148-017-0319-5 DO - 10.1186/s13148-017-0319-5 ID - Issa2017 ER - TY - JOUR AU - Tandon, N. AU - Ramakrishnan, V. AU - Kumar, S. K. PY - 2016 DA - 2016// TI - Clinical use and applications of histone deacetylase inhibitors in multiple myeloma JO - Clin Pharmacol VL - 8 ID - Tandon2016 ER - TY - JOUR AU - Ola Rizq, N. M. AU - Koide, S. AU - Ma, A. AU - Jin, J. AU - Iseki, T. AU - Nakaseko, C. AU - Iwama, A. PY - 2014 DA - 2014// TI - EZH2 inhibition and the combination with proteasome inhibition are novel potential strategies for the treatment of multiple myeloma JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-01-547927 DO - 10.1182/blood-2014-01-547927 ID - Ola Rizq2014 ER - TY - JOUR AU - Kikuchi, J. AU - Wada, T. AU - Shimizu, R. AU - Izumi, T. AU - Akutsu, M. AU - Mitsunaga, K. PY - 2010 DA - 2010// TI - Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma JO - Blood VL - 116 UR - https://doi.org/10.1182/blood-2009-07-235663 DO - 10.1182/blood-2009-07-235663 ID - Kikuchi2010 ER - TY - JOUR AU - Hideshima, T. AU - Cottini, F. AU - Ohguchi, H. AU - Jakubikova, J. AU - Gorgun, G. AU - Mimura, N. PY - 2015 DA - 2015// TI - Rational combination treatment with histone deacetylase inhibitors and immunomodulatory drugs in multiple myeloma JO - Blood Cancer J VL - 5 UR - https://doi.org/10.1038/bcj.2015.38 DO - 10.1038/bcj.2015.38 ID - Hideshima2015 ER - TY - JOUR AU - Kaufman, J. L. AU - Fabre, C. AU - Lonial, S. AU - Richardson, P. G. PY - 2013 DA - 2013// TI - Histone deacetylase inhibitors in multiple myeloma: rationale and evidence for their use in combination therapy JO - Clin Lymphoma Myeloma Leuk VL - 13 UR - https://doi.org/10.1016/j.clml.2013.03.016 DO - 10.1016/j.clml.2013.03.016 ID - Kaufman2013 ER - TY - JOUR AU - Tagliaferri, P. AU - Rossi, M. AU - Martino, M. T. AU - Amodio, N. AU - Leone, E. AU - Gulla, A. PY - 2012 DA - 2012// TI - Promises and challenges of MicroRNA-based treatment of multiple myeloma JO - Curr Cancer Drug Targets VL - 12 UR - https://doi.org/10.2174/156800912802429355 DO - 10.2174/156800912802429355 ID - Tagliaferri2012 ER - TY - JOUR AU - Ahmad, N. AU - Haider, S. AU - Jagannathan, S. AU - Anaissie, E. AU - Driscoll, J. J. PY - 2014 DA - 2014// TI - MicroRNA theragnostics for the clinical management of multiple myeloma JO - Leukemia VL - 28 UR - https://doi.org/10.1038/leu.2013.262 DO - 10.1038/leu.2013.262 ID - Ahmad2014 ER - TY - JOUR AU - Mithraprabhu, S. AU - Khong, T. AU - Spencer, A. PY - 2014 DA - 2014// TI - Overcoming inherent resistance to histone deacetylase inhibitors in multiple myeloma cells by targeting pathways integral to the actin cytoskeleton JO - Cell Death Dis VL - 5 UR - https://doi.org/10.1038/cddis.2014.98 DO - 10.1038/cddis.2014.98 ID - Mithraprabhu2014 ER - TY - JOUR AU - Wang, X. AU - Li, C. AU - Ju, S. AU - Wang, Y. AU - Wang, H. AU - Zhong, R. PY - 2011 DA - 2011// TI - Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation JO - Leuk Lymphoma VL - 52 UR - https://doi.org/10.3109/10428194.2011.591004 DO - 10.3109/10428194.2011.591004 ID - Wang2011 ER - TY - JOUR AU - Murray, M. Y. AU - Rushworth, S. A. AU - Zaitseva, L. AU - Bowles, K. M. AU - Macewan, D. J. PY - 2013 DA - 2013// TI - Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression JO - Cell Cycle VL - 12 UR - https://doi.org/10.4161/cc.25251 DO - 10.4161/cc.25251 ID - Murray2013 ER - TY - JOUR AU - Roccaro, A. M. AU - Sacco, A. AU - Thompson, B. AU - Leleu, X. AU - Azab, A. K. AU - Azab, F. PY - 2009 DA - 2009// TI - MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2009-01-198408 DO - 10.1182/blood-2009-01-198408 ID - Roccaro2009 ER - TY - JOUR AU - Hao, M. AU - Zhang, L. AU - An, G. AU - Sui, W. AU - Yu, Z. AU - Zou, D. PY - 2011 DA - 2011// TI - Suppressing miRNA-15a/-16 expression by interleukin-6 enhances drug-resistance in myeloma cells JO - J Hematol Oncol VL - 4 UR - https://doi.org/10.1186/1756-8722-4-37 DO - 10.1186/1756-8722-4-37 ID - Hao2011 ER - TY - JOUR AU - Hentati-Kallel, M. AU - Jan, S. AU - Bernard, P. AU - Antonicelli, F. AU - Trussardi-Regnier, A. PY - 2017 DA - 2017// TI - Histone deacetylases meet microRNA-associated MMP-9 expression regulation in glucocorticoid-sensitive and -resistant cell lines JO - Int J Oncol VL - 50 ID - Hentati-Kallel2017 ER - TY - JOUR AU - Xi, H. AU - Li, L. AU - Du, J. AU - An, R. AU - Fan, R. AU - Lu, J. PY - 2017 DA - 2017// TI - hsa-miR-631 resensitizes bortezomib-resistant multiple myeloma cell lines by inhibiting UbcH10 JO - Oncol Rep VL - 37 ID - Xi2017 ER - TY - JOUR AU - Shen, X. AU - Guo, Y. AU - Qi, J. AU - Shi, W. AU - Wu, X. AU - Ni, H. PY - 2016 DA - 2016// TI - Study on the association between miRNA-202 expression and drug sensitivity in multiple myeloma cells JO - Pathol Oncol Res VL - 22 UR - https://doi.org/10.1007/s12253-015-0035-4 DO - 10.1007/s12253-015-0035-4 ID - Shen2016 ER - TY - JOUR AU - Zhao, J. J. AU - Lin, J. AU - Zhu, D. AU - Wang, X. AU - Brooks, D. AU - Chen, M. PY - 2014 DA - 2014// TI - miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/beta-catenin/BCL9 pathway JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-13-3311-T DO - 10.1158/0008-5472.CAN-13-3311-T ID - Zhao2014 ER - TY - JOUR AU - Wu, P. AU - Agnelli, L. AU - Walker, B. A. AU - Todoerti, K. AU - Lionetti, M. AU - Johnson, D. C. PY - 2013 DA - 2013// TI - Improved risk stratification in myeloma using a microRNA-based classifier JO - Br J Haematol VL - 162 UR - https://doi.org/10.1111/bjh.12394 DO - 10.1111/bjh.12394 ID - Wu2013 ER - TY - JOUR AU - Huang, J. J. AU - Yu, J. AU - Li, J. Y. AU - Liu, Y. T. AU - Zhong, R. Q. PY - 2012 DA - 2012// TI - Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma JO - Med Oncol VL - 29 UR - https://doi.org/10.1007/s12032-012-0210-3 DO - 10.1007/s12032-012-0210-3 ID - Huang2012 ER - TY - JOUR AU - Lionetti, M. AU - Biasiolo, M. AU - Agnelli, L. AU - Todoerti, K. AU - Mosca, L. AU - Fabris, S. PY - 2009 DA - 2009// TI - Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma JO - Blood VL - 114 UR - https://doi.org/10.1182/blood-2009-08-237495 DO - 10.1182/blood-2009-08-237495 ID - Lionetti2009 ER - TY - JOUR AU - Pichiorri, F. AU - Suh, S. S. AU - Ladetto, M. AU - Kuehl, M. AU - Palumbo, T. AU - Drandi, D. PY - 2008 DA - 2008// TI - MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0806202105 DO - 10.1073/pnas.0806202105 ID - Pichiorri2008 ER - TY - JOUR AU - Gutierrez, N. C. AU - Sarasquete, M. E. AU - Misiewicz-Krzeminska, I. AU - Delgado, M. AU - De Las Rivas, J. AU - Ticona, F. V. PY - 2010 DA - 2010// TI - Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling JO - Leukemia VL - 24 UR - https://doi.org/10.1038/leu.2009.274 DO - 10.1038/leu.2009.274 ID - Gutierrez2010 ER - TY - JOUR AU - Misiewicz-Krzeminska, I. AU - Sarasquete, M. E. AU - Quwaider, D. AU - Krzeminski, P. AU - Ticona, F. V. AU - Paino, T. PY - 2013 DA - 2013// TI - Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication JO - Haematologica VL - 98 UR - https://doi.org/10.3324/haematol.2012.070011 DO - 10.3324/haematol.2012.070011 ID - Misiewicz-Krzeminska2013 ER - TY - JOUR AU - Zhang, Y. K. AU - Wang, H. AU - Leng, Y. AU - Li, Z. L. AU - Yang, Y. F. AU - Xiao, F. J. PY - 2011 DA - 2011// TI - Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1 JO - Biochem Biophys Res Commun VL - 414 UR - https://doi.org/10.1016/j.bbrc.2011.09.063 DO - 10.1016/j.bbrc.2011.09.063 ID - Zhang2011 ER - TY - JOUR AU - Pichiorri, F. AU - Suh, S. S. AU - Rocci, A. AU - Luca, L. AU - Taccioli, C. AU - Santhanam, R. PY - 2010 DA - 2010// TI - Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development JO - Cancer Cell VL - 18 UR - https://doi.org/10.1016/j.ccr.2010.09.005 DO - 10.1016/j.ccr.2010.09.005 ID - Pichiorri2010 ER - TY - JOUR AU - Canella, A. AU - Cordero Nieves, H. AU - Sborov, D. W. AU - Cascione, L. AU - Radomska, H. S. AU - Smith, E. PY - 2015 DA - 2015// TI - HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide JO - Oncotarget VL - 6 ID - Canella2015 ER - TY - STD TI - Wu C, Ruan T, Liu W, Zhu X, Pan J, Lu W, et al. Effect and mechanism of curcumin on EZH2 - miR-101 regulatory feedback loop in multiple myeloma. Curr Pharm Des. 2017. ID - ref91 ER -